mhurhangee/patent-ind-claim-en huggingface dataset:
A system for the hot-dip galvanization of components for large-scale hot-dip galvanization comprising a plurality of identical or similar components with a conveyor device having at least one goods carrier for conveying the components , a flux application device for the application of a flux on the surface of the components and a hot-dip galvanization device for the hot-dip galvanization of the components with a galvanization bath comprising a molten zinc-aluminium alloy, wherein the goods carrier is designed for the receiving and for the transport of at least one separated component , wherein the flux application device comprises a spraying device for the automated spray application of the flux onto the surface of the separated component , wherein a control device which is coupled to the spraying device for the automatic spraying of the flux is provided for the automated control of the spray application depending on the shape and/or type and/or material and/or surface quality of the component , wherein the control device is designed so that the spray application is homogeneous and/or is individually adapted to the component and wherein the control device is provided for the automated control of the thickness of the spray application on the component and/or the concentration of the flux and/or the spraying duration of the spray application per component and/or the spraying duration of the spray application for different areas of a component and/or the simultaneous spray application of different flux and/or different flux components, wherein the spraying device comprises a plurality of spray heads , wherein at least one spray head is movable in the X direction and/or in the Y direction and/or in the Z direction relative to the component .
A building block linkage element , wherein the building block linkage element comprises at least a first stud having a longitudinal axis (X) and a second stud having a longitudinal axis (X'), wherein the first stud and the second stud comprises at least one slot , wherein at least one link extends between the first stud and the second stud and is rotatably attached to the first stud by means of at least one pivot and to the second stud by means of at least one pivot , characterised in that the link has at least one lock , which is pivotable about a pin , and a stop for the lock .
Non-therapeutic, ex vivo, or in vitro use of a spider silk polypeptide for reducing the formation of a biofilm.
An anesthesia machine, wherein the anesthesia machine comprises: a gas source interface , an anesthesia ventilation circuit, an anesthetic evaporator , a host case , a main control board , a display apparatus and a power supply interface ; wherein the host case comprises a main rack case and a main control case arranged above the main rack case ; the gas source interface and the power supply interface are arranged on the host case , and the anesthetic evaporator is detachably connected to the host case ; the anesthesia ventilation circuit connects with the gas source interface , and at least part of the anesthesia ventilation circuit is arranged in the host case ; the display apparatus includes a display device and a display shell for fixing the display device , characterized in that the display apparatus is installed at an upper end of the main control case by means of a display supporting frame; and the main control board is arranged on a side of the display shell opposite to the display device , and the power supply interface electrically connects with the main control board and the display device . the gas source interface and the power supply interface are arranged on the host case , and the anesthetic evaporator is detachably connected to the host case ; the anesthesia ventilation circuit connects with the gas source interface , and at least part of the anesthesia ventilation circuit is arranged in the host case ; the display apparatus includes a display device and a display shell for fixing the display device , characterized in that the display apparatus is installed at an upper end of the main control case by means of a display supporting frame; and the main control board is arranged on a side of the display shell opposite to the display device , and the power supply interface electrically connects with the main control board and the display device .
A mixer, comprising: a mixer body including an outer container , a pulverizing blade and a blade driving unit configured to rotate the pulverizing blade ; an inner container unit including an inner container disposed within the outer container , provided with the pulverizing blade , and including a lateral opening formed therein, and an inner container driving unit configured to rotate the inner container ; and a dewatering unit including a dewatering container configured to block the lateral opening by surrounding the inner container so as to accommodate the mixing object therein and to have a dewatering hole therein, characterized in that : the dewatering unit further includes a dewatering container speed change device configured to change a rotational speed of the dewatering container , and the mixer further comprises a scraper configured to protrude from an outer side surface of the inner container to scrape off a blocking component of the mixing object blocking the dewatering hole of the dewatering container when there is a difference in the rotational speeds betweeen the inner container and the dewatering container . a mixer body including an outer container , a pulverizing blade and a blade driving unit configured to rotate the pulverizing blade ; an inner container unit including an inner container disposed within the outer container , provided with the pulverizing blade , and including a lateral opening formed therein, and an inner container driving unit configured to rotate the inner container ; and a dewatering unit including a dewatering container configured to block the lateral opening by surrounding the inner container so as to accommodate the mixing object therein and to have a dewatering hole therein, characterized in that : the dewatering unit further includes a dewatering container speed change device configured to change a rotational speed of the dewatering container , and the mixer further comprises a scraper configured to protrude from an outer side surface of the inner container to scrape off a blocking component of the mixing object blocking the dewatering hole of the dewatering container when there is a difference in the rotational speeds betweeen the inner container and the dewatering container . the dewatering unit further includes a dewatering container speed change device configured to change a rotational speed of the dewatering container , and the mixer further comprises a scraper configured to protrude from an outer side surface of the inner container to scrape off a blocking component of the mixing object blocking the dewatering hole of the dewatering container when there is a difference in the rotational speeds betweeen the inner container and the dewatering container .
A composite peptide selenoprotein nutrient solution, comprising selenium-containing material, hydrolysate of protein, natural mineral, acetic acid, EDTA, penetrating agent, trace element additives, vitamin supplements, organic silicone, soluble modified starch, emulsifier, and water, said water being obtained after a filtration of drinking water through sand, carbon and membrane and the nano-tech electric ion exchange equipment, the composite peptide selenoprotein nutrient solution comprising the aforesaid elements according to the following ratios (in weight): selenium-containing material, 1-3%, natural mineral, 0.5‰ which is one or more from tourmaline, volcanic rock or volcanic ash , protein material, 2-3%, acetic acid, 1-5 ‰, EDTA, 0.5∼1‰, penetrating agent, 1 ‰ which is methanol or ethylene glycol, trace element additives, 6-10 ‰ consisting in zinc 1-3 ‰; magnesium 1-2 ‰; manganese 1-2.5 ‰; molybdenum 0.1-0.15 ‰; boron 2-3 ‰, vitamin supplements, 0.2-0.3 ‰, organic silicone 1 ‰ , soluble starch, 1%, emulsifier, 1.5%- 5% which is glycerin monostearate (GMS), sodium stearyl lactate (ssl), calcium stearyl lactate (csl), diacetyl tartaric acid esters of mono-and diglycerides (datem), sugar esters (se) or distilled monoglycerides (dmg), and filtered water, 87-93%.
A drug delivery device , comprising: a housing comprising one or more bridging contacts ; a movable dial located at least partially within the housing and arranged to move relative to the one or more bridging contacts , the dial comprising a series of conductive strips on an exterior surface of the dial , wherein the series of conductive strips comprise at least one source strip connected to a battery and at least one sensor strip connected to at least one electronic component, wherein the one or more bridging contacts selectively connect and disconnect a source strip to a sensor strip as the movable dial moves to provide alternating electrical signals, wherein the one or more bridging contacts are not connected to the at least one electronic component except when connected via a sensor strip; wherein the at least one electronic component is configured to: detect the alternating electrical signals; determine whether the electrical signals are indicative of contact between conductive strips and bridging contact; and based on said electrical signals, determine a medicament dosage dialled into the drug delivery device. a housing comprising one or more bridging contacts ; a movable dial located at least partially within the housing and arranged to move relative to the one or more bridging contacts , the dial comprising a series of conductive strips on an exterior surface of the dial , wherein the series of conductive strips comprise at least one source strip connected to a battery and at least one sensor strip connected to at least one electronic component, wherein the one or more bridging contacts selectively connect and disconnect a source strip to a sensor strip as the movable dial moves to provide alternating electrical signals, wherein the one or more bridging contacts are not connected to the at least one electronic component except when connected via a sensor strip; wherein the at least one electronic component is configured to: detect the alternating electrical signals; determine whether the electrical signals are indicative of contact between conductive strips and bridging contact; and based on said electrical signals, determine a medicament dosage dialled into the drug delivery device. detect the alternating electrical signals; determine whether the electrical signals are indicative of contact between conductive strips and bridging contact; and based on said electrical signals, determine a medicament dosage dialled into the drug delivery device.
An aluminium alloy multi-layered brazing sheet product for brazing in an inert-gas atmosphere without a flux, comprising: a core layer made of a 3xxx alloy comprising 0.20% to 0.75 wt. % Mg, and provided with a covering clad layer comprising 2 wt. % to 5 wt. % Si on one or both sides of the 3xxx alloy core layer; and a AI-Si brazing clad layer comprising 7 wt. % to 13 wt. % Si positioned between the 3xxx alloy core layer and the covering clad layer, wherein the covering clad layer has a thickness X 1 and the AI-Si brazing clad layer has a thickness X 2 and wherein X 2 ≥ 2X 1 . a core layer made of a 3xxx alloy comprising 0.20% to 0.75 wt. % Mg, and provided with a covering clad layer comprising 2 wt. % to 5 wt. % Si on one or both sides of the 3xxx alloy core layer; and a AI-Si brazing clad layer comprising 7 wt. % to 13 wt. % Si positioned between the 3xxx alloy core layer and the covering clad layer, wherein the covering clad layer has a thickness X 1 and the AI-Si brazing clad layer has a thickness X 2 and wherein X 2 ≥ 2X 1 .
A method of identifying a metastatic castration resistant prostate cancer (mCRPC) patient with an improved response to taxane therapy compared to androgen receptor signaling-directed (ARS-directed) therapy comprising: (a) performing a direct analysis comprising immunofluorescent staining and morphological characterization of nucleated cells in a blood sample from the patient to generate circulating tumor cell (CTC) data, wherein the direct analysis means the detection of the CTCs in the context of all surrounding nucleated cells present in the sample as opposed to after enrichment of the sample for CTCs prior to detection, and wherein the direct analysis comprises detecting the presence of an Androgen Receptor Variant 7 (AR-V7) in said cells, and (b) evaluating the CTC data to identify an mCRPC patient with an improved response to taxane therapy compared to ARS-directed therapy, wherein the presence of an Androgen Receptor Variant 7 in said CTCs identifies a mCRPC patient with an improved response to taxane therapy compared to ARS-directed therapy (a) performing a direct analysis comprising immunofluorescent staining and morphological characterization of nucleated cells in a blood sample from the patient to generate circulating tumor cell (CTC) data, wherein the direct analysis means the detection of the CTCs in the context of all surrounding nucleated cells present in the sample as opposed to after enrichment of the sample for CTCs prior to detection, and wherein the direct analysis comprises detecting the presence of an Androgen Receptor Variant 7 (AR-V7) in said cells, and wherein the direct analysis means the detection of the CTCs in the context of all surrounding nucleated cells present in the sample as opposed to after enrichment of the sample for CTCs prior to detection, and wherein the direct analysis comprises detecting the presence of an Androgen Receptor Variant 7 (AR-V7) in said cells, and (b) evaluating the CTC data to identify an mCRPC patient with an improved response to taxane therapy compared to ARS-directed therapy, wherein the presence of an Androgen Receptor Variant 7 in said CTCs identifies a mCRPC patient with an improved response to taxane therapy compared to ARS-directed therapy
An apparatus , the apparatus comprising: an expandable structure comprising a balloon, the expandable structure configured for insertion into a body of a subject; and a plurality of conducting elements printed onto the surface of the balloon , each of the conducting elements comprising a respective coil and having: an insulated portion that is electrically insulated from tissue of the subject, and an uninsulated portion configured to exchange signals with the tissue, while in contact with the tissue. an expandable structure comprising a balloon, the expandable structure configured for insertion into a body of a subject; and a plurality of conducting elements printed onto the surface of the balloon , each of the conducting elements comprising a respective coil and having: an insulated portion that is electrically insulated from tissue of the subject, and an uninsulated portion configured to exchange signals with the tissue, while in contact with the tissue. an insulated portion that is electrically insulated from tissue of the subject, and an uninsulated portion configured to exchange signals with the tissue, while in contact with the tissue.
A session processing method, comprising: receiving (S901), by a policy control function network element, request information from an application function network element, wherein the request information comprises a continuity requirement of an application and the request information is for determination of session policy information, wherein the continuity requirement indicates whether an internet protocol, IP, address used by a user equipment to access a server of the application remains unchanged; determining (S902), by the policy control function network element, the session policy information based on the request information, comprising: in response to that the continuity requirement indicates that the IP address used by the user equipment to access the server of the application remains unchanged, determining the session policy indicating that an anchor user plane function network element for accessing the server of the application keeps unchanged; and sending (S903), by the policy control function network element, the session policy information to a session management function network element, wherein the session policy information is for processing of a session receiving (S901), by a policy control function network element, request information from an application function network element, wherein the request information comprises a continuity requirement of an application and the request information is for determination of session policy information, wherein the continuity requirement indicates whether an internet protocol, IP, address used by a user equipment to access a server of the application remains unchanged; determining (S902), by the policy control function network element, the session policy information based on the request information, comprising: in response to that the continuity requirement indicates that the IP address used by the user equipment to access the server of the application remains unchanged, determining the session policy indicating that an anchor user plane function network element for accessing the server of the application keeps unchanged; and sending (S903), by the policy control function network element, the session policy information to a session management function network element, wherein the session policy information is for processing of a session
Knitting tool bar of a warp knitting machine having a base body which is formed as a hollow profile, characterized in that the base body is formed from steel.
A connection device for radiators that comprises: - a reducing plug configured to adapt a radiator outlet to the size of the thread of a valve or a lockshield valve, wherein the reducing plug comprises a first joining end for joining to the radiator ; wherein the reducing plug further comprises a second end configured to carry out the coupling of a nut ; and wherein the second end of the reducing plug comprises a hollow interior part which in turn comprises at least one first stretch with a first diameter and at least one second stretch with a second diameter that is smaller than the first diameter; characterized in that the first end for joining to the radiator is larger than the second end and comprises an external thread configured to join the reducing plug to the radiator . - a reducing plug configured to adapt a radiator outlet to the size of the thread of a valve or a lockshield valve, wherein the reducing plug comprises a first joining end for joining to the radiator ; wherein the reducing plug further comprises a second end configured to carry out the coupling of a nut ; and wherein the second end of the reducing plug comprises a hollow interior part which in turn comprises at least one first stretch with a first diameter and at least one second stretch with a second diameter that is smaller than the first diameter; characterized in that the first end for joining to the radiator is larger than the second end and comprises an external thread configured to join the reducing plug to the radiator .
An electrosurgical instrument for making an end-to-end anastomosis between two hollow organ sections comprising two tools movable relative to each other, each including an electrode , preferably an HF electrode, by which the hollow organ sections can be fusion-welded to each other, wherein the two tools are substantially sleeve-shaped or at least can assume a sleeve shape so that a first tool can enclose a first hollow organ section and a second tool can enclose a second hollow organ section , each of the electrodes is formed at an end face of the sleeve-shaped tools around which the respective hollow organ section can be everted inside out; the two tools are movable relative to each other so that the electrodes are aligned and can clamp the everted hollow organ sections between them; and each of the sleeve-shaped tools is formed of a pair of half shells which can be moved toward and away from each other, especially can be swiveled toward and away from each other, and in the closed position are adapted to receive the respective hollow organ section between them; wherein the two pairs of half shells are supported on an instrument body to be axially movable relative toward and away from each other and rotatable in the circumferential direction, characterized in that cranks are provided which define the rotational movement and the axial displacement of the two tools , and stops are provided for limiting the maximum degree of opening of the half shells .
One component reaction system for production of rigid polyurethane foams that comprises the following constituents: A) an organic polyisocyanate component partially or completely in the form of a prepolymer, B) an isocyanate-reactive component whose functional groups are exclusively those having at least one Zerewitinoff-reactive hydrogen atom and also, optionally, at least one halogen atom, C) at least one stabilizer, D) at least one catalyst suitable for catalyzing the reaction of said polyisocyanate component A) with said isocyanate-reactive component B), and also E) optionally auxiliary and added-substance materials and also blowing agent and co-blowing agent, characterized in that said stabilizer C) is selected from the group of polyether-polydialkoxysilane copolymers and has a cloud point of not less than 50°C measured in a 4 wt% aqueous solution of the stabilizer and incrementally raising the temperature from 20°C starting at a heating rate of 2°C/min and ascertaining the cloud point by visually judging the onset of clouding. A) an organic polyisocyanate component partially or completely in the form of a prepolymer, B) an isocyanate-reactive component whose functional groups are exclusively those having at least one Zerewitinoff-reactive hydrogen atom and also, optionally, at least one halogen atom, C) at least one stabilizer, D) at least one catalyst suitable for catalyzing the reaction of said polyisocyanate component A) with said isocyanate-reactive component B), and also E) optionally auxiliary and added-substance materials and also blowing agent and co-blowing agent,
A method for diagnosing a mild traumatic brain injury (mTBI) in a subject, or for identifying a subject at risk of suffering from a mild traumatic brain injury (mTBI)-associated abnormality in white matter structure or long-term dysfunction, the method comprising: analyzing a blood, serum, or plasma sample obtained from the subject within 24 hours of the injury to determine the level of a biomarker associated with the presence of mTBI, and comparing the level of the biomarker to the level of a pre-determined standard, wherein the biomarker is a calpain-cleaved αII-spectrin N-terminal fragment (SNTF), thereby diagnosing the mTBI in the subject or identifying a subject at risk of suffering from a mild traumatic brain injury (mTBI)-associated abnormality in white matter structure or a long-term dysfunction.